{
    "clinical_study": {
        "@rank": "25287", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Determine whether combined intercostal muscle and diaphragm pacing can\n      maintain full-time ventilatory support in patients with ventilatory dependent quadriplegia\n      who are not candidates for phrenic nerve pacing alone.\n\n      II.  Evaluate the efficacy of the Medlink device to produce synchronous intercostal and\n      diagram activation in these patients."
        }, 
        "brief_title": "Study of Combined Intercostal and Diaphragm Pacing for Artificial Respiration in Quadriplegic Patients", 
        "condition": "Quadriplegia", 
        "condition_browse": {
            "mesh_term": "Quadriplegia"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: Patients have a Medlink spinal cord electrode surgically implanted and\n      attached to a radiofrequency receiver implanted subcutaneously over the anterior chest wall.\n\n      If substantial inspired volumes can be generated by intercostal pacing, a phrenic nerve cuff\n      electrode and radiofrequency receiver are implanted, and patients undergo combined\n      intercostal muscle and diaphragm pacing."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics--\n\n        Ventilator dependent quadriplegics who are not candidates for phrenic nerve pacing alone\n\n        Must have bilateral partial or unilateral phrenic nerve function\n\n        Must have been on ventilator support for at least 6 months and unweanable\n\n        --Patient Characteristics--\n\n        Cardiovascular: No active cardiovascular disease\n\n        Pulmonary: No active lung disease\n\n        Other: No active brain disease Stable condition"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "49 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "5", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004415", 
            "org_study_id": "199/13307", 
            "secondary_id": [
                "CWRU-09169-M-91", 
                "CWRU-FDR000403"
            ]
        }, 
        "intervention": {
            "intervention_name": "Medlink spinal cord electrode", 
            "intervention_type": "Device"
        }, 
        "keyword": [
            "environmental/toxic disorders", 
            "neurologic and psychiatric disorders", 
            "rare disease", 
            "spinal cord injury"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "Case Western Reserve University", 
            "last_name": "Anthony F. DiMarco", 
            "role": "Study Chair"
        }, 
        "overall_status": "Suspended", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004415"
        }, 
        "source": "FDA Office of Orphan Products Development", 
        "sponsors": {
            "collaborator": {
                "agency": "Case Western Reserve University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "FDA Office of Orphan Products Development", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "May 1991", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2002"
    }, 
    "geocoordinates": {}
}